Cargando…
Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD)
[Image: see text] Psilocybin, a serotonergic agonist, was granted a “breakthrough therapy” status by the Food and Drug Administration for clinical trials involving major depressive disorder and treatment-resistant depression. The direct phosphorylation of psilocin to psilocybin that uses a fast crys...
Autores principales: | Kargbo, Robert B., Sherwood, Alexander M., Meisenheimer, Poncho, Lenoch, Kelsey, Abebe, Solomon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851641/ https://www.ncbi.nlm.nih.gov/pubmed/35187358 http://dx.doi.org/10.1021/acsomega.1c06708 |
Ejemplares similares
-
Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples
por: Sherwood, Alexander M., et al.
Publicado: (2022) -
Direct Phosphorylation of Psilocin Enables Optimized
cGMP Kilogram-Scale Manufacture of Psilocybin
por: Kargbo, Robert B., et al.
Publicado: (2020) -
Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin
por: Fricke, Janis, et al.
Publicado: (2020) -
Effects of CO(3)(2−) and OH(−) on the solubility, metastable zone width and nucleation kinetics of borax decahydrate
por: Chen, Jing, et al.
Publicado: (2019) -
Comparison of the Nucleation Kinetics Obtained from the Cumulative Distributions of the Metastable Zone Width and Induction Time Data
por: Shiau, Lie-Ding
Publicado: (2022)